Literature DB >> 23828659

Comparison of three methods (an updated logistic probabilistic method, the Naranjo and Liverpool algorithms) for the evaluation of routine pharmacovigilance case reports using consensual expert judgement as reference.

Hélène Théophile1, Manon André, Ghada Miremont-Salamé, Yannick Arimone, Bernard Bégaud.   

Abstract

BACKGROUND: An updated probabilistic causality assessment method and the Liverpool algorithm presented as an improved version of the Naranjo algorithm, one of the most used and accepted causality assessment methods, have recently been proposed.
OBJECTIVE: In order to test the validity of the probabilistic method in routine pharmacovigilance, results provided by the Naranjo and Liverpool algorithms, as well as the updated probabilistic method, were each compared with a consensual expert judgement taken as reference.
METHODS: A sample of 59 drug-event pairs randomly sampled from spontaneous reports to the French pharmacovigilance system was assessed by expert judgement until reaching consensus and by members of a pharmacovigilance unit using the updated probabilistic method, the Naranjo and Liverpool algorithms. Probabilities given by the probabilistic method, and categories obtained by both the Naranjo and the Liverpool algorithms were compared as well as their sensitivity, specificity, positive and negative predictive values.
RESULTS: The median probability for drug causation given by the consensual expert judgement was 0.70 (inter-quartile range, IQR 0.54-0.84) versus 0.77 (IQR 0.54-0.91) for the probabilistic method. For the Naranjo algorithm, the 'possible' causality category was predominant (61 %), followed by 'probable' (35 %), 'doubtful', and 'almost certain' categories (2 % each). Category distribution obtained with the Liverpool algorithm was similar to that obtained by the Naranjo algorithm with a majority of 'possible' (61 %) and 'probable' (30 %) followed by 'definite' (7 %) and 'unlikely' (2 %). For the probabilistic method, sensitivity, specificity, positive and negative predictive values were 0.96, 0.56, 0.92 and 0.71, respectively. For the Naranjo algorithm, depending on whether the 'possible' category was considered in favour or in disfavour of drug causation, sensitivity was, respectively, 1 or 0.42, specificity 0.11 or 0.89, negative predictive value 1 or 0.22 and positive predictive value 0.86 or 0.95; results were identical for the Liverpool algorithm.
CONCLUSION: The logistic probabilistic method gave results closer to the consensual expert judgment than either the Naranjo or Liverpool algorithms whose performance were strongly dependent on the meaning given to the 'possible' category. Owing to its good sensitivity and positive predictive value and by providing results as continuous probabilities, the probabilistic method seems worthy to use for a trustable assessment of adverse drug reactions in routine practice.

Mesh:

Substances:

Year:  2013        PMID: 23828659     DOI: 10.1007/s40264-013-0083-1

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  30 in total

1.  A quantitative approach of using genetic algorithm in designing a probability scoring system of an adverse drug reaction assessment system.

Authors:  Yvonne Koh; Chun Wei Yap; Shu Chuen Li
Journal:  Int J Med Inform       Date:  2007-10-24       Impact factor: 4.046

2.  Consistency between causality assessments obtained with two scales and their agreement with clinical judgments in hepatotoxicity.

Authors:  Milena M Miljkovic; Silva Dobric; Viktorija Dragojevic-Simic
Journal:  Pharmacoepidemiol Drug Saf       Date:  2011-01-10       Impact factor: 2.890

3.  An updated method improved the assessment of adverse drug reaction in routine pharmacovigilance.

Authors:  Hélène Théophile; Manon André; Yannick Arimone; Françoise Haramburu; Ghada Miremont-Salamé; Bernard Bégaud
Journal:  J Clin Epidemiol       Date:  2012-10       Impact factor: 6.437

4.  Sources of information on lymphoma associated with anti-tumour necrosis factor agents: comparison of published case reports and cases reported to the French pharmacovigilance system.

Authors:  Hélène Théophile; Thierry Schaeverbeke; Ghada Miremont-Salamé; Abdelilah Abouelfath; Valentine Kahn; Françoise Haramburu; Bernard Bégaud
Journal:  Drug Saf       Date:  2011-07-01       Impact factor: 5.606

5.  Computer-assisted evaluation of adverse events using a Bayesian approach.

Authors:  K L Lanctôt; C A Naranjo
Journal:  J Clin Pharmacol       Date:  1994-02       Impact factor: 3.126

6.  The ambiguity of adverse drug reactions.

Authors:  J Koch-Weser; E M Sellers; R Zacest
Journal:  Eur J Clin Pharmacol       Date:  1977-01-03       Impact factor: 2.953

7.  An algorithm for the operational assessment of adverse drug reactions. III. Results of tests among clinicians.

Authors:  J M Leventhal; T A Hutchinson; M S Kramer; A R Feinstein
Journal:  JAMA       Date:  1979-11-02       Impact factor: 56.272

8.  Adverse drug events in an intensive care unit of a university hospital.

Authors:  Adriano Max Moreira Reis; Silvia Helena De Bortoli Cassiani
Journal:  Eur J Clin Pharmacol       Date:  2011-01-19       Impact factor: 2.953

9.  Evaluation of naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury.

Authors:  M García-Cortés; M I Lucena; K Pachkoria; Y Borraz; R Hidalgo; R J Andrade
Journal:  Aliment Pharmacol Ther       Date:  2008-02-18       Impact factor: 8.171

10.  Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes.

Authors:  Emma C Davies; Christopher F Green; Stephen Taylor; Paula R Williamson; David R Mottram; Munir Pirmohamed
Journal:  PLoS One       Date:  2009-02-11       Impact factor: 3.240

View more
  14 in total

1.  Comparison of different methods for causality assessment of adverse drug reactions.

Authors:  Sapan Kumar Behera; Saibal Das; Alphienes Stanley Xavier; Srinivas Velupula; Selvarajan Sandhiya
Journal:  Int J Clin Pharm       Date:  2018-07-26

2.  Preliminary Results of a Novel Algorithmic Method Aiming to Support Initial Causality Assessment of Routine Pharmacovigilance Case Reports for Medication-Induced Liver Injury: The PV-RUCAM.

Authors:  Erik Scalfaro; Henk Johan Streefkerk; Michael Merz; Christoph Meier; David Lewis
Journal:  Drug Saf       Date:  2017-08       Impact factor: 5.606

Review 3.  Vitamin B6 in Health Supplements and Neuropathy: Case Series Assessment of Spontaneously Reported Cases.

Authors:  Florence van Hunsel; Sonja van de Koppel; Eugène van Puijenbroek; Agnes Kant
Journal:  Drug Saf       Date:  2018-09       Impact factor: 5.606

4.  Atrial fibrillation following treatment with paclitaxel: A case report.

Authors:  Dehua Zhao; Jing Chen; Xiaojun Liu; Xiaoqing Long; Lisha Cao; Jisheng Wang
Journal:  Biomed Rep       Date:  2018-10-12

5.  The Association between Metformin Therapy and Lactic Acidosis.

Authors:  Isabelle H S Kuan; Ruth L Savage; Stephen B Duffull; Robert J Walker; Daniel F B Wright
Journal:  Drug Saf       Date:  2019-12       Impact factor: 5.606

6.  Self-medication with over-the-counter and prescribed drugs causing adverse-drug-reaction-related hospital admissions: results of a prospective, long-term multi-centre study.

Authors:  Sven Schmiedl; Marietta Rottenkolber; Joerg Hasford; Dominik Rottenkolber; Katrin Farker; Bernd Drewelow; Marion Hippius; Karen Saljé; Petra Thürmann
Journal:  Drug Saf       Date:  2014-04       Impact factor: 5.606

Review 7.  Causality assessment between reported fatal cerebral haemorrhage and suspected drugs: developing a new algorithm based on the analysis of the Japanese Adverse Event Report (JADER) database and literature review.

Authors:  Miki Ohta
Journal:  Eur J Clin Pharmacol       Date:  2021-04-07       Impact factor: 2.953

8.  A New-Onset Rash in the Setting of Rifaximin Treatment for Hepatic Encephalopathy.

Authors:  Cassandra D L Fritz; Corlan Adebajo; Andrew Aronsohn; Donald M Jensen
Journal:  ACG Case Rep J       Date:  2014-10-10

Review 9.  Dilemmas of the causality assessment tools in the diagnosis of adverse drug reactions.

Authors:  Lateef M Khan; Sameer E Al-Harthi; Abdel-Moneim M Osman; Mai A Alim A Sattar; Ahmed S Ali
Journal:  Saudi Pharm J       Date:  2015-01-10       Impact factor: 4.330

Review 10.  Saudi Vigilance Program: Challenges and lessons learned.

Authors:  Adel Alharf; Nasser Alqahtani; Ghazi Saeed; Ali Alshahrani; Mubarak Alshahrani; Nasser Aljasser; Mohammed Alquwaizani; Saleh Bawazir
Journal:  Saudi Pharm J       Date:  2018-01-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.